This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through September 7, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Microcap Article: Archive
CNTM Falls 52% in Six Months: Should You Buy the Dip or Wait?
by Debasmita Chatterjee
ConnectM's mounting financial pressure from operating losses, a $29.8 million working capital deficit and rising debt costs weigh on performance.
CNTMNegative Net Change REKRNegative Net Change BSYNegative Net Change
computers tech-stocks
AERG Advances Laser Technology With Improved Power & Range
by Urbashi Dutta
Applied Energetics advances laser technology with improved power and precision, paving the way for extended-range counter-drone and portable defense systems.
AERGNegative Net Change
tech-stocks
SolarMax Q2 Loss Widens Y/Y on Legal Costs Despite 49% Revenue Growth
by Zacks Equity Research
SMXT reports 49% y/y revenue growth in Q2, but a $4.3M legal charge widens losses. Strong solar and LED sales lift gross profit.
SMXTPositive Net Change
earnings oil-energy
Zacks Initiates Coverage of CISO Global With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates CISO Global as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore CISO's improving cost discipline and growing cybersecurity software adoption amid weak core services and rising financial obligations.
CISONegative Net Change
cybersecurity internet tech-stocks
Zacks Initiates Coverage of Momentus With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates Momentus as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore MNTS' growing government contracts and expanding space missions amid financing dependence and execution uncertainties.
MNTSNegative Net Change
aerospace defense
Weyco Stock Surges 79% in the Past Year: Time to Buy, Hold or Sell?
by Debasmita Chatterjee
WEYS' wholesale revenue growth, BOGS recovery, rising online sales and strong liquidity position the footwear company for expansion in the days ahead.
WEYSPositive Net Change CALPositive Net Change BIRKPositive Net Change
consumer-discretionary
UTMD Trades at a Premium to the Industry: How to Play the Stock?
by Debasmita Chatterjee
Utah Medical's Orion acquisition, strong cash reserves, improving margins and product expansion efforts support growth prospects and continued shareholder returns.
UTMDPositive Net Change EOLSNegative Net Change CGCPositive Net Change
medical
SIFCO Stock Surges Nearly 310% YTD: What's Behind the Rally?
by Debanjana Dey
SIF's strong defense demand, growing aerospace backlog and operational improvements support growth prospects despite profitability and supply-chain challenges.
SIFNegative Net Change CVUNo Net Change OPXSNegative Net Change
aerospace defense
Jones Soda Posts 196% Y/Y Revenue Growth in Q3, Eyes Retail Expansion
by Urbashi Dutta
JSDA remains on track to meet its 2026 sales and EBITDA targets while eyeing retail expansion and new partnerships.
JSDAPositive Net Change
consumer-staples
Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy?
by Debanjana Dey
ELTP and AYTU have different CNS portfolios, growth drivers and valuations, but which pharmaceutical stock looks better positioned? Let's dive in.
ELTPNo Net Change AYTUPositive Net Change
biotechnology biotechs medical pharmaceuticals